Login

Houlihan Lokey CEO Scott Beiser celebrates the firm's IPO at the NYSE, discussing M&A activity and key trends in restructuring. 00:10:00

Share On Facebook Share On Twitter

Scott Beiser is a Co-Chairman of Houlihan Lokey

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
We understand that every client has a unique investment goal|Leow Kai Chuen,Vice President,Paragon Capital Management
00:10:00
Emerson Resources: Advancing High-Grade Gold and Copper Projects in Australia
00:00:00
JOHAN EMILSSON Chief Executive Officer, Sprint Bioscience
00:10:00
Chris Hellman: Insights on Activist Investing and Corporate Improvement | Chris Hellman - Chief Investment Officer of the California State Teachers Retirement System
00:10:00
Strategies for Managing Inflation: Insights from Scott Sturgeon | Scott Sturgeon, Founder, Oread Wealth Partners.
00:10:00
"Strategy Update for B-DYNAMIC BOND: Impact of Fed’s Interest Rate Delay and Portfolio Management Insights"
00:10:00
Tailored Investment Strategies for Individual Clients
00:10:00
Discover What Sets Pathway Financial Advisors Apart in Their Latest Video
00:10:00
AGCO CEO Discusses Grain Price Surge Amid Ukraine War | ERIC HANSOTIA - Chairman, President & CEO of AGCO Corp
00:10:00
Interview with John Delo, CEO of Abitibi Metals Corp: Strategic Insights and Team Overview
00:10:00
Interview with Brian O'Neal: From Air Force Pilot to Financial Advisor | Brian O'Neil, CEO, Winged Wealth Management and Financial Planning LLC
00:10:00
Setting Boundaries with Kyle Moore, CFP | Kyle Moore - FOUNDER, FINANCIAL PLANNER of Quarry Hill Advisors

© 2026 Nehu